Helen M. Thackray, Chief R&D Officer: Biocryst Pharmaceuticals BCRX Planned sale · Filed 25/11/21

Trade details

Type: Planned sale notice
Stock: Biocryst Pharmaceuticals BCRX
Person: Helen M. ThackrayChief R&D Officer
Planned sale date: 25/11/21
Filed: 25/11/21

$307.7K to be sold

Biocryst Pharmaceuticals trades, last 26 weeks

What else happened in Biocryst Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/10/22~25/12/21

Helen M. Thackray's recent trades

Helen M. ThackrayChief R&D Officer
Planned saleBiocryst Pharmaceuticals
Planned sale
Biocryst Pharmaceuticals
BCRX
$328K
48,229 sh
$328K
Filed 25/11/25
Traded 25/11/25
Helen M. ThackrayChief R&D Officer
BuyBiocryst Pharmaceuticals
Buy
Biocryst Pharmaceuticals
BCRX
$175.8K
30,000 sh
$175.8K
Filed 24/05/15
Traded 24/05/14
Helen M. ThackrayChief R&D Officer
Sell10b5-1 planBiocryst Pharmaceuticals
Sell10b5-1 plan
Biocryst Pharmaceuticals
BCRX
$58K
7,000 sh
$58K
Filed 23/04/05
Traded 23/04/03

Helen M. Thackray, Chief Officer — plans to sell 43,275 sh of Biocryst Pharmaceuticals BCRX · $307.7K · around 11/21 | Whalegun